Drug Target Validation
Drug Target Validation is a methodological process in reverse chemical genetics that confirms the biological relevance and therapeutic potential of a molecular target by establishing a causal relationship between modulating the target and a desired phenotypic outcome.
638
Publications
34.3K
Citations
4.8K
Authors
1.2K
Institutions
Publications per year
2017–2026
260
Parents
638
Genetic drug target validation using Mendelian randomisation
Amand F. Schmidt, Chris Finan, María Gordillo‐Marañón et al. · Nature Communications · 2020 · 605 citations · Full text
1–5 of 638
4.8K
13
h-index
10
h-index
10
h-index
9
h-index
7
h-index
1–5 of 4.8K
1.2K

University of Dundee
Dundee, United Kingdom
27 h-index
205 publications
12.7K citations

Centre National de la Recherche Scientifique
Paris, France
15 h-index
50 publications
2.3K citations
Heidelberg University
Heidelberg, Germany
14 h-index
80 publications
3.8K citations
Harvard University
Cambridge, United States
13 h-index
77 publications
5.4K citations
Inserm
Paris, France
12 h-index
30 publications
1.1K citations
University of California, San Francisco
San Francisco, United States
11 h-index
29 publications
2K citations

Monash University
Melbourne, Australia
11 h-index
28 publications
993 citations

Imperial College London
London, United Kingdom
11 h-index
24 publications
1.6K citations
1–8 of 1.2K
40 publications · 2.3K citations
28
h-index
20 publications · 780 citations
17
h-index
Repository · 21 publications · 979 citations
17
h-index
PNAS · 16 publications · 1.9K citations
16
h-index
AAC · 17 publications · 823 citations
15
h-index
1–5